DETERMINING THE EFFICACY OF NLX-112 IN A MOUSE EXPERIMENTAL MODEL OF CEREBELLAR ATAXIA

$861,486FY2019Department of the ArmyDOD

Neurolixis Inc

Investigators

View source on USAspending →